RTW INVESTMENTS, LP Diversified Active

Location: New York, NY

CIK: 0001493215 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value: $1.387B (100.0% shares, 0.0% debt)

Holdings (40)

RCKT Rocket Pharmaceuticals Inc 20.9%
Value $289M Shares 14,969,744 Est. Cost $16.31 Unrealized +16.0%
RGNX Regenxbio Inc 10.8%
Value $149M Shares 2,079,555 Est. Cost $24.63 Unrealized +93.9%
PTCT Ptc Therapeutics Inc 9.9%
Value $137M Shares 4,073,690 Est. Cost $13.46 Unrealized +131.6%
SRPT Sarepta Therapeutics Inc 9.3%
Value $129M Shares 978,551 Est. Cost $74.88 Unrealized +25.9%
ARWR Arrowhead Pharmaceuticals In 8.1%
Value $113M Shares 8,299,542 Est. Cost $8.23 Unrealized +13.6%
Dicerna Pharmaceuticals Inc 4.5%
Value $61.8M Shares 5,044,813 Est. Cost $10.56 Unrealized
BMY Bristol Myers Squibb Co 3.6%
Value $50.01M Shares 903,672 Est. Cost $43.52 Unrealized -6.6%
LIVN Livanova PLC 3.1%
Value $43.02M Shares 431,000 Est. Cost $88.96 Unrealized +2.0%
La Jolla Pharmaceutical Co 2.8%
Value $39.26M Shares 1,345,881 Est. Cost $26.28 Unrealized
Achillion Pharmaceuticals In 2.8%
Value $38.32M Shares 13,541,997 Est. Cost $3.82 Unrealized
ABUS Arbutus Biopharma Corp 2.7%
Value $37.71M Shares 5,165,499 Est. Cost $3.27 Unrealized +82.2%
ALNY Alnylam Pharmaceuticals Inc 2.5%
Value $34.69M Shares 352,200 Est. Cost $82.31 Unrealized +20.5%
MASI Masimo Corp 1.8%
Value $24.37M Shares 249,543 Est. Cost $77.72 Unrealized +22.3%
Solid Biosciences Inc 1.6%
Value $22.75M Shares 675,771 Est. Cost $6.82 Unrealized
VCEL Vericel Corp 1.6%
Value $21.51M Shares 2,217,916 Est. Cost $6.40 Unrealized +94.6%
Agenus Inc 1.5%
Value $21.28M Shares 9,375,451 Est. Cost $6.00 Unrealized
Qiagen NV 1.4%
Value $19.14M Shares 529,385 Est. Cost $36.16 Unrealized
QURE Uniqure NV 1.1%
Value $15.47M Shares 409,370 Est. Cost $15.23 Unrealized +110.3%
Corium Intl Inc 1.1%
Value $15.4M Shares 1,923,217 Est. Cost $8.35 Unrealized
ILMN Illumina Inc 1.0%
Value $13.87M Shares 49,658 Est. Cost $254.40 Unrealized 0.0%
Myokardia Inc 0.9%
Value $12.98M Shares 261,395 Est. Cost $42.84 Unrealized
VRAYQ Viewray Inc 0.7%
Value $10.2M Shares 1,474,156 Est. Cost $6.41 Unrealized +13.3%
Polarityte Inc 0.7%
Value $10.04M Shares 426,670 Est. Cost $23.54 Unrealized
CDNA Caredx Inc 0.7%
Value $9.358M Shares 764,532 Est. Cost $7.58 Unrealized +51.3%
Bovie Medical Corp 0.7%
Value $9.057M Shares 2,082,137 Est. Cost $3.19 Unrealized
Electrocore Inc 0.6%
Value $8.338M Shares 505,000 Est. Cost $16.51 Unrealized
Nuvectra Corp 0.6%
Value $7.864M Shares 383,030 Est. Cost $13.02 Unrealized
Viveve Med Inc 0.6%
Value $7.782M Shares 2,861,023 Est. Cost $4.34 Unrealized
Odonate Therapeutics Inc 0.4%
Value $6.102M Shares 276,368 Est. Cost $22.75 Unrealized
STIM Neuronetics Inc 0.4%
Value $5.056M Shares 190,000 Est. Cost $27.20 Unrealized 0.0%
Homology Medicines Inc 0.3%
Value $4.619M Shares 226,431 Est. Cost $18.70 Unrealized
Novavax Inc 0.3%
Value $3.543M Shares 2,644,346 Est. Cost $2.10 Unrealized
Vivus Inc 4.5 05/01/2020 0.2%
Value $3.14M Shares 4,000,000 Est. Cost $0.79 Unrealized
Proteostasis Therapeutics In 0.2%
Value $3.006M Shares 1,077,408 Est. Cost $5.83 Unrealized
ARGX Argenx Se 0.2%
Value $2.118M Shares 25,559 Est. Cost $21.81 Unrealized
Novus Therapeutics Inc 0.2%
Value $2.113M Shares 301,799 Est. Cost $5.04 Unrealized
Tapimmune Inc 0.1%
Value $1.886M Shares 200,000 Est. Cost $9.43 Unrealized
Bellicum Pharmaceuticals Inc 0.1%
Value $1.109M Shares 150,289 Est. Cost $7.38 Unrealized
Adverum Biotechnologies Inc 0.1%
Value $935K Shares 176,372 Est. Cost $5.80 Unrealized
Motus Gi Hldgs Inc 0.0%
Value $428K Shares 59,478 Est. Cost $4.48 Unrealized